 |
|
|
Press ReleasesArbovax, Inc. and Immunobiosciences, Inc Announce a Collaborative Agreement on Dengue Vaccine ResearchRaleigh, NC (May 20, 2008) - Arbovax, Inc (Arbovax) and Immunobiosciences, Inc (IBI) today announced that they will initiate research collaboration on the development of safe and effective vaccines for dengue, a viral disease that is transmitted by mosquitoes. Read more. |
Recent NewsMay 2008: Two Raleigh-based biotechnology companies, Arbovax, Inc., and Immunobiosciences, Inc., are teaming up to develop a safe and effective vaccine for dengue, a viral disease transmitted by mosquitoes. View the North Carolina Biotechnology Center announcement. |